Life Sciences BPO Market - Global Industry Analysis and Forecast, 2013 - 2019


Posted February 25, 2015 by andreadevis

This research report provides a detailed analysis of the global life sciences BPO market and helps in understanding the various driving factors for the growth of the market.

 
Contract manufacturing is a concept favored by the recent army of big and successful manufacturers. Reducing cost helps a company to assign its investments into other areas like branding, marketing and other sales promoting activities that require constant attention. Manufacturing and research units are among the integral part of a company’s whole business process. However, they can also run on their own once given proper direction, as they do not require constant tweaking, nor involve sudden change in requirements in comparison to other segments. A research unit particularly is nearly independent once a project is initiated.

Browse Here For Full Report With ToC:http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

These processes would only lead to a better product, and not necessarily, a better brand presence or market share, both of which require great deal of planning and routine changes of strategies in case something goes different than expected. Most pharmaceutical and medical device giants have adopted the strategy of outsourcing to specialist service providers such as contract manufacturing organizations (CMOs) and contract research organizations (CROs). Besides cost, these CMO’s help reduce stagnancy in productivity volume and cost pressures and arrest the concerns for any regulatory changes. The recent economic downturn, rise in demand for generic drugs and patent expirations have compelled the pharmaceutical companies to outsource their R&D and manufacturing activities to such CMO’s.
We are currently offering a flat 15% discount on all purchases until end of the March 2015!
The life sciences BPO market comprises services offered by contract manufacturing organizations (CMOs) and contract research organizations (CROs) to the biotech/pharmaceutical companies. Pharmaceutical companies are now forming long-term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for effective outcomes.
This research report provides a detailed analysis of the global life sciences BPO market and helps in understanding the various driving factors for the growth of the market. The market overview section of this report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of this market. The executive summary provides detailed insights about the report and the market in general. It also provides a market snapshot, which in ways a glimpse into the present scenario of the life sciences BPO market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global life sciences BPO market.
The report further discusses the market of life sciences BPO on the basis of different CRO and CMO services. The CRO services comprise of clinical data management, monitoring, medical writing, regulatory services, pharmacovigilance, bio-statistics, drug discovery and pre-clinical tests. The CMO services include API manufacturing, finished dosage formulation development and manufacturing and packaging.

Click Here For Upcoming Health care IT Reports :http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

The global life sciences BPO market has been segmented based on all the above- mentioned parameters and market size estimates and forecasts for the period of 2013 to 2019 have been provided for each of the segments, in terms of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.
The report exclusively studies the aforementioned segments with respect to geography. Under geographic market section, four regional markets, namely, North America, Europe, Asia-Pacific and Rest of the World (ROW) have been analyzed. Moreover, the European region has been further studied by various countries including U.K., Germany, France, Spain, Italy and Rest of Europe (ROE).

The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Catalent Pharma Solutions, Inc., PRA International, Inc., Covance, Inc., Cognizant Technology Solutions, Quintiles Transnational Corporation, Parexel International Corporation, DSM, Charles River Laboratories, Piramal Healthcare and Boehringer Ingelheim GmbH. 
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Website life-sciences-bpo-market
Phone +1-518-618-1030
Business Address Transparency Market Research 90 State Street, Suite 700, Albany
NY - 12207 United States
Country United States
Categories Health , Marketing , Reports
Tags life sciences bpo market , life sciences bpo market analysis , life sciences bpo market forecast , life sciences bpo market structure
Last Updated February 25, 2015